Ayden Scheim holds a PhD in Epidemiology and Biostatistics from Western University in London, Canada, where he was a Pierre Elliott Trudeau Foundation Scholar and Vanier Canada Graduate Scholar. He is currently a Canadian Institutes of Health Research Postdoctoral Fellowship in the Division of Infectious Diseases and Global Public Health at University of California, San Diego. Dr. Scheim investigates the impacts of social and policy environments on the health of stigmatized populations. In particular, his current research program focuses on infectious disease and behavioural health among transgender persons and people who inject drugs, both domestically and globally. He is also Senior Policy Analyst at the International Centre for Science in Drug Policy.
Dr. Scheim’s doctoral research examined the impacts of discrimination on health behaviours among transgender (trans) people in Ontario, Canada, and developed a new instrument for measuring discrimination intersectionally in population health research. His postdoctoral research will focus on the social context of injection drug use initiation among sexual and gender minorities, and potential prevention strategies.
Beyond his doctoral and postdoctoral projects, Dr. Scheim maintains an active program of interdisciplinary and community-engaged research. Recent projects include a study of supervised injection service feasibility in two mid-sized Canadian cities, a qualitative study of trans men who have sex with men in Ontario, and analyses of data from the Trans PULSE Project, the largest Canadian survey of trans adult health. He also provides research, evaluation, and training services as a consultant. All of Dr. Scheim’s work is informed by over a decade of front-line experience providing trans health, HIV prevention, and harm reduction services.